Dr. Reddy's Laboratories (RDY) reported fiscal Q4 earnings Friday of $0.22 per diluted share, up from $0.18 a year earlier.
One analyst polled by FactSet expected $0.20.
Revenue for the quarter ended March 31 was $996 million, up from $829 million a year earlier.
One analyst surveyed by FactSet expected $1.01 billion.
Shares of the company were up 1.8% in recent trading.
Price: 13.42, Change: +0.23, Percent Change: +1.78